Platelet Transfusion
Publication Date: November 28, 2017
Key Points
Key Points
Prophylactic platelet transfusion should be administered to patients with thrombocytopenia resulting from impaired bone marrow function to reduce the risk of hemorrhage when the platelet count falls below a predefined threshold level.
Recommended thresholds for prophylactic platelet transfusion are provided for patients with hematologic malignacies or solid tumors, and those undergoing hematopoietic stem cell transplantation or invasive procedures.
Guidance is also provided regarding the production of platelet products, prevention of Rh alloimmunization, and management of refractoriness to platelet transfusion.
Recommended thresholds for prophylactic platelet transfusion are provided for patients with hematologic malignacies or solid tumors, and those undergoing hematopoietic stem cell transplantation or invasive procedures.
Guidance is also provided regarding the production of platelet products, prevention of Rh alloimmunization, and management of refractoriness to platelet transfusion.
Treatment
...eatmen...
...f Platelet ProductsPlatelets for t...
...AlloimmunizationUPDATED. Preventio...
...koreductionUPDATED. The incidence of alloan...
...rophylactic vs Therapeutic Platelet Transf...
...elet Transfusion Threshold in Patients with Hem...
...Transfusion Threshold in the Settin...
...et Transfusion in Patients with Chr...
...sfusion Threshold in Patients With Solid Tu...
Platelet Count at which Surgical or I...
...toring for Refractoriness to Platelet TransfusionU...
...anaging Refractoriness to Platelet Tra...